1 July 2022 - The July 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
24 June 2022 - ...
23 June 2022 - Filsuvez will be the first and only approved treatment for epidermolysis bullosa patients. ...
23 June 2022 - Approval based on the ground-breaking DESTINY-Breast03 Phase 3 trial, showing Enhertu reduced the risk of disease ...
23 June 2022 - Designation follows positive interim Phase 1/2 data for BNT211 demonstrating an encouraging safety profile and early signs ...
24 June 2022 - Application targets treatment of moderate to severe vasomotor symptoms associated with menopause ...
23 June 2022 - It was precisely 30 years ago, in 1992, that the FDA established the accelerated approval program ...
23 June 2022 - The US FDA on Thursday released draft guidance explaining its thought process for rescinding breakthrough therapy ...
23 June 2022 - Thousands of doses of expensive anti-viral drugs could be wasted if more Australians do not become ...
23 June 2022 - EMA has recommended granting a marketing authorisation for COVID-19 Vaccine (inactivated, adjuvanted) Valneva for use in ...
22 June 2022 - The Tufts Cost-Effectiveness Analysis Registry was used to identify all CEAs published in Medline between 1976 and ...
23 June 2022 - EMA’s CHMP has recommended granting an extension of indication for the COVID-19 vaccine Nuvaxovid to include use ...
20 June 2022 - Innovent Biologics and Eli Lilly today announced that the Center for Drug Evaluation of China's National ...
22 June 2022 - NICE has announced its decision to reject Fampyra – also known as fampridine – for use ...
23 June 2022 - To 19 June 2022, the TGA has received 581 reports which have been assessed as likely to ...
22 June 2022 - Priority review requested; if accepted, anticipate an 8 month FDA review. ...